Sharma, M D <br/><br/>
Potential for combination of dipeptidyl peptidase-4 inhibitors and sodium-glucose co-transporter-2 inhibitors for the treatment of type 2 diabetes.  [electronic resource] 

 -  Diabetes, obesity & metabolism  Jul 2015 
 - 616-21 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/dom.12451  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Glucose--drug effects<br/>Diabetes Mellitus, Type 2--blood<br/>Dipeptidyl-Peptidase IV Inhibitors--therapeutic use<br/>Drug Therapy, Combination<br/>Glycated Hemoglobin--drug effects<br/>Humans<br/>Sodium-Glucose Transporter 2 Inhibitors